Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
NCT06831643Recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in acute liver failure (ALF) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Native liver survival at Day 21. Started Feb 2025; status: recruiting.
02
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT06831643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06831643.